Lung Cancer Europe shared on X:
“The evidence for low-dose CT lung cancer screening is clear. The challenge now is delivery. IARC has concluded that screening reduces lung cancer deaths and advanced-stage diagnoses in people at high risk. Across Europe, access remains uneven.”
You might be interested in:
Early-Stage NSCLC in 2026: From Treatment Intensification to Precision-Guided Curative Strategies
